HuGE Literature Finder
Records
1
-
11
| Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer. European review for medical and pharmacological sciences 2019 Nov 23 (21): 9393-9410. Pu J, Wang N, Huang Z-K, He X-Y, Yuan H |
| Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management. The journal of applied laboratory medicine 2019 05 3 (6): 954-964. Hosseinnejad Keivan, Yin Tyler, Gaskins Jeremy T, Stauble M Elaine, Wu Yanhong, Jannetto Paul, Langman Loralie L, Jortani Saeed |
| Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects. Basic & clinical pharmacology & toxicology 2018 Oct . Saiz-Rodríguez Miriam, Ochoa Dolores, Herrador Coral, Belmonte Carmen, Román Manuel, Alday Enrique, Koller Dora, Zubiaur Pablo, Mejía Gina, Hernández-Martínez María, Abad-Santos Francis |
| Relationship between the plasma fentanyl and serum 4ß-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. Drug metabolism and pharmacokinetics 2016 Jun 31 (3): 242-8. Ishida Takuya, Naito Takafumi, Sato Hikaru, Kawakami Junic |
| Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study. Clinical therapeutics 2015 Nov . Bosilkovska Marija, Ing Lorenzini Kuntheavy, Uppugunduri Chakradhara Rao S, Desmeules Jules, Daali Youssef, Escher Moni |
| Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenetics and genomics 2014 Apr 24 (4): 185-94. Barratt Daniel T, Bandak Benedikte, Klepstad Pål, Dale Ola, Kaasa Stein, Christrup Lona L, Tuke Jonathan, Somogyi Andrew |
| Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. International journal of clinical pharmacology and therapeutics 2013 May 51 (5): 383-92. Kim Kye-Min, Kim Ho-Sook, Lim Se Hun, Cheong Soon Ho, Choi Eun-Jung, Kang Hyun, Choi Hey-Ran, Jeon Jin-Woo, Yon Jun Heum, Oh Minkyung, Shin Jae-Go |
| Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity. Cancer chemotherapy and pharmacology 2011 Dec 68 (6): 1633-8. Guilhaumou Romain, Solas Caroline, Bourgarel-Rey Veronique, Quaranta Sylvie, Rome Angelique, Simon Nicolas, Lacarelle Bruno, Andre Nicol |
| Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery. European journal of anaesthesiology 2011 Apr 28 (4): 245-50. Zhang Wei, Yuan Jing-Jing, Kan Quan-Cheng, Zhang Li-Rong, Chang Yan-Zi, Wang Zhong-Yu, Li Zhi-So |
| A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state. Cancer chemotherapy and pharmacology 2009 Feb 63 (3): 477-89. O'Bryant C L, Lieu C H, Leong S, Boinpally R, Basche M, Gore L, Leonardi K, Schultz M K, Hariharan S, Chow L, Diab S, Gibbs A, Eckhardt S |
| The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clinical pharmacology and therapeutics 2005 Nov 78 (5): 551-8. Fiegenbaum Marilu, da Silveira Fabiano R, Van der Sand Cézar R, Van der Sand Luiz Carlos, Ferreira Maria E W, Pires Renan C, Hutz Mara |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: